MS

11 registered clinical trials studyying MS — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	"Selfie" Videos: A Novel, Patient-centered, Comprehensive Approach to Measuring Function in MS NCT07222618	University of California, San Francisco	—
Recruiting	Clinical Study on Targeted CD19/BCMA CAR-T Therapy for Autoimmune Diseases NCT06775912	Nanjing Bioheng Biotech Co., Ltd.	EARLY_Phase 1
Active Not Recruiting	KYSA-7: A Study of Anti-CD19 CAR T-Cell Therapy, in Subjects With Refractory Primary and Secondary Progressive NCT06384976	Kyverna Therapeutics	Phase 2
Withdrawn	A Study of RD06-04 in Patients With Active Autoimmune Diseases NCT06548620	Nanjing Bioheng Biotech Co., Ltd.	EARLY_Phase 1
Active Not Recruiting	A Closed Loop, Doctor to Patient, Mobile Application for Depression in People With Multiple Sclerosis NCT05865405	University of California, San Francisco	N/A
Unknown	Blood Flow Restriction Training in Multiple Sclerosis NCT06143930	Cairo University	N/A
Enrolling By Invitation	Macromolecular Imaging of White and Gray Matter Pathology in Multiple Sclerosis NCT04415372	University of Wisconsin, Madison	—
Withdrawn	A Pilot Study to Explore the Role of Gut Flora in Multiple Sclerosis NCT04148313	ProgenaBiome	—
Completed	Evaluating Multiple Sclerosis Patients ShOWing A GEnomic Signature of Therapy Response NCT03316404	DxTerity Diagnostics	—
Completed	Robotics for Mobility Rehabilitation in MS NCT05102682	East Kent Hospitals University NHS Foundation Trust	Phase 1
Completed	Treatment Adherence When Using RebiSmart™ in Relapsing Multiple Sclerosis Subjects NCT01128075	Merck KGaA, Darmstadt, Germany	—